A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in the lab. Built from patient-derived stem cells and immune cells, it ...
A new 3D human brain tissue platform developed by MIT researchers is the first to integrate all major brain cell types, including neurons, glial cells and the vasculature into a single culture. Grown ...
With an AI-led platform for drug discovery and a growing global client base, Medvolt AI is emerging as one of India’s most ...
Once a drug target is identified, it often takes decades until a chemical compound is developed that can hit the bullseye and ...
Microsoft launches MAI Superintelligence Team led by Mustafa Suleyman, focusing on “humanist” AI models for healthcare, ...
In particular, organ-on-chip technology (such as React4Life’s platform) facilitates growth and analysis of patient-derived tissue samples. This capability enables researchers to potentially ...
Wharton's Peter Cappelli shares eye-opening research on the impact of AI on a company's productivity and headcount.
6don MSN
Computer Chips in Our Bodies Could Be the Future of Medicine. These Patients Are Already There
In this system, the implanted computer chip would not just sit on the brain, but become part of the brain. Using a technology ...
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced the closing of its previously announced securities purchase agreement with a single healthcare institutional investor for the ...
Announces $6 Million Registered Direct Offering With Concurrent Private Placement Of Warrants. NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage company developing broad-spectrum antiviral ...
The Trump administration has admitted that they are not trying to identify anyone aboard boats they accuse of sending drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback